Share Price and Basic Stock Data
Last Updated: November 10, 2025, 4:22 pm
| PEG Ratio | 108.35 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Checkpoint Trends Ltd operates within the pharmaceuticals industry, focusing on the production and distribution of pharmaceutical products. The company reported a market capitalization of ₹35.2 Cr and a current share price of ₹64.3. Over the years, revenue trends have exhibited volatility; sales stood at ₹2.01 Cr in FY 2022, declining to ₹1.16 Cr in FY 2023, and slightly rebounding to ₹1.13 Cr in FY 2024. The trailing twelve months (TTM) sales surged to ₹12.11 Cr, indicating a significant increase in sales activity. Quarterly sales figures fluctuated sharply, with the highest recorded at ₹0.62 Cr in Mar 2022 and the lowest at ₹0.05 Cr in Sep 2024. Such revenue volatility may be reflective of market demand dynamics or operational challenges. The company’s ability to stabilize revenue streams will be crucial in maintaining investor confidence and ensuring long-term sustainability.
Profitability and Efficiency Metrics
Checkpoint Trends Ltd’s profitability metrics reveal a challenging landscape. The company’s reported net profit was a mere ₹0.09 Cr, and the profit margins exhibited significant fluctuations, with an operating profit margin (OPM) of 36% in Mar 2025 following a low of -137.5% in Mar 2023. The return on equity (ROE) stood at 9.17%, while the return on capital employed (ROCE) was recorded at 16.5%, indicating moderate efficiency in generating returns from shareholders’ equity and capital employed. The interest coverage ratio (ICR) was robust at 111.40x, suggesting that the company can easily cover its interest obligations, although it reported no borrowings. However, the cash conversion cycle (CCC) extended to 211.70 days, which is high and may point to inefficiencies in inventory management or collection practices. These metrics highlight strengths in liquidity but raise concerns about operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Checkpoint Trends Ltd demonstrates a conservative capital structure, with total borrowings recorded at ₹0.00 Cr and negative reserves of ₹4.91 Cr. The company’s total assets amounted to ₹0.65 Cr, while total liabilities were slightly higher at ₹0.93 Cr. The price-to-book value (P/BV) ratio stood at 12.54x, indicating that the market values the company significantly higher than its book value, which may reflect investor optimism. The current and quick ratios were reported at 6.92x, showcasing strong liquidity and the company’s ability to meet short-term obligations. However, the negative reserves could pose a risk to financial stability if not addressed promptly. The historical context of fluctuating profitability and operational performance emphasizes the need for strategic measures to enhance asset utilization and profitability.
Shareholding Pattern and Investor Confidence
Checkpoint Trends Ltd’s shareholding pattern reflects a notable shift in investor confidence. As of Mar 2025, foreign institutional investors (FIIs) held 10.86% of the equity, a significant increase from previous quarters where their holdings were recorded at 0%. The public shareholding stood at 89.14%, indicating a strong retail investor presence, with the number of shareholders rising to 2,416. The absence of domestic institutional investors (DIIs) may suggest a lack of confidence from larger institutional players, which could impact the stock’s stability. The steady increase in FII participation, however, could signal growing interest in the company’s potential recovery and operational improvements. This evolving shareholding landscape will be crucial for future capital raising efforts and overall market perception.
Outlook, Risks, and Final Insight
Checkpoint Trends Ltd faces both opportunities and risks moving forward. The recent uptick in TTM sales indicates potential for revenue recovery, but the company must address its high cash conversion cycle and negative reserves to improve operational efficiency and financial health. The presence of FIIs could foster a more favorable market environment, provided the company can demonstrate consistent profitability. Key risks include ongoing volatility in revenue, regulatory challenges in the pharmaceutical sector, and the need for effective inventory management. Should the company successfully implement strategic initiatives to enhance its operational framework, it could stabilize its revenue streams while improving investor confidence. Conversely, failure to address these operational inefficiencies could lead to continued financial instability and deter potential investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Checkpoint Trends Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 136 Cr. | 108 | 247/84.3 | 31.0 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,937 Cr. | 453 | 479/192 | 102 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.4 Cr. | 45.1 | 92.2/37.2 | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 37.3 Cr. | 25.4 | 29.1/17.0 | 38.8 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 19,998.92 Cr | 1,191.15 | 55.95 | 199.13 | 0.34% | 16.24% | 14.95% | 6.10 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.62 | 0.51 | 0.36 | 0.21 | 0.08 | 0.20 | 0.29 | 0.17 | 0.47 | 0.10 | 0.05 | 0.10 | 0.25 |
| Expenses | 0.63 | 0.49 | 0.35 | 0.21 | 0.19 | 0.25 | 0.03 | 0.11 | 0.71 | 0.07 | 0.08 | 0.14 | 0.16 |
| Operating Profit | -0.01 | 0.02 | 0.01 | 0.00 | -0.11 | -0.05 | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.04 | 0.09 |
| OPM % | -1.61% | 3.92% | 2.78% | 0.00% | -137.50% | -25.00% | 89.66% | 35.29% | -51.06% | 30.00% | -60.00% | -40.00% | 36.00% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | -0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | 0.02 | 0.01 | 0.00 | -0.11 | -0.05 | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.02 | 0.07 |
| Tax % | 100.00% | 50.00% | 0.00% | -9.09% | 0.00% | 0.00% | 0.00% | -4.17% | 0.00% | 33.33% | 0.00% | 0.00% | |
| Net Profit | -0.02 | 0.01 | 0.01 | 0.00 | -0.10 | -0.05 | 0.26 | 0.06 | -0.23 | 0.02 | -0.04 | -0.02 | 0.06 |
| EPS in Rs | -0.04 | 0.02 | 0.02 | 0.00 | -0.18 | -0.09 | 0.48 | 0.11 | -0.42 | 0.04 | -0.07 | -0.04 | 0.11 |
Last Updated: May 31, 2025, 6:32 am
Below is a detailed analysis of the quarterly data for Checkpoint Trends Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 0.25 Cr.. The value appears strong and on an upward trend. It has increased from 0.10 Cr. (Dec 2024) to 0.25 Cr., marking an increase of 0.15 Cr..
- For Expenses, as of Mar 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.14 Cr. (Dec 2024) to 0.16 Cr., marking an increase of 0.02 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.09 Cr.. The value appears strong and on an upward trend. It has increased from -0.04 Cr. (Dec 2024) to 0.09 Cr., marking an increase of 0.13 Cr..
- For OPM %, as of Mar 2025, the value is 36.00%. The value appears strong and on an upward trend. It has increased from -40.00% (Dec 2024) to 36.00%, marking an increase of 76.00%.
- For Other Income, as of Mar 2025, the value is -0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Dec 2024) to -0.02 Cr., marking a decrease of 0.04 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Dec 2024) to 0.07 Cr., marking an increase of 0.09 Cr..
- For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
- For Net Profit, as of Mar 2025, the value is 0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Dec 2024) to 0.06 Cr., marking an increase of 0.08 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.11. The value appears strong and on an upward trend. It has increased from -0.04 (Dec 2024) to 0.11, marking an increase of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:40 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.20 | 0.31 | 2.30 | 0.59 | 0.99 | 0.49 | 2.01 | 1.16 | 1.13 | 0.50 | 12.11 |
| Expenses | 0.06 | 0.07 | 0.21 | 0.28 | 2.33 | 0.77 | 0.97 | 0.48 | 2.03 | 1.24 | 1.10 | 0.40 | 12.00 |
| Operating Profit | -0.06 | -0.07 | -0.01 | 0.03 | -0.03 | -0.18 | 0.02 | 0.01 | -0.02 | -0.08 | 0.03 | 0.10 | 0.11 |
| OPM % | -5.00% | 9.68% | -1.30% | -30.51% | 2.02% | 2.04% | -1.00% | -6.90% | 2.65% | 20.00% | 0.91% | ||
| Other Income | 0.00 | -3.00 | 0.00 | 0.00 | -0.13 | 0.17 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Profit before tax | -0.06 | -3.07 | -0.01 | 0.03 | -0.16 | -0.01 | 0.05 | 0.01 | -0.02 | -0.08 | 0.02 | 0.05 | 0.11 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 20.00% | 0.00% | 50.00% | 0.00% | -50.00% | 40.00% | |
| Net Profit | -0.06 | -3.07 | -0.01 | 0.03 | -0.16 | -0.01 | 0.03 | 0.01 | -0.04 | -0.08 | 0.03 | 0.03 | 0.09 |
| EPS in Rs | -0.11 | -5.61 | -0.02 | 0.05 | -0.29 | -0.02 | 0.05 | 0.02 | -0.07 | -0.15 | 0.05 | 0.05 | 0.16 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -5016.67% | 99.67% | 400.00% | -633.33% | 93.75% | 400.00% | -66.67% | -500.00% | -100.00% | 137.50% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 5116.34% | 300.33% | -1033.33% | 727.08% | 306.25% | -466.67% | -433.33% | 400.00% | 237.50% | -137.50% |
Checkpoint Trends Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -13% |
| 3 Years: | -37% |
| TTM: | 1076% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 25% |
| 3 Years: | 40% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 79% |
| 3 Years: | 128% |
| 1 Year: | 328% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -2% |
| 3 Years: | -1% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:56 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36.50 | 23.55 | 53.96 | 179.41 | 106.92 | 163.88 | 121.67 | 135.30 | 229.34 | 211.70 | ||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 36.50 | 23.55 | 53.96 | 179.41 | 106.92 | 163.88 | 121.67 | 135.30 | 229.34 | 211.70 | ||
| Working Capital Days | 18.25 | -35.32 | 36.50 | 259.83 | 221.21 | 59.59 | 98.06 | 129.01 | 145.35 | 386.90 | ||
| ROCE % | -1.62% | -3.42% | -2.56% | 7.41% | 25.49% | -30.51% | 3.33% | 1.61% | -3.31% | -12.80% | 3.36% | 16.51% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.05 | 0.06 | -0.14 | -0.07 | 0.01 |
| Diluted EPS (Rs.) | 0.05 | 0.06 | -0.14 | -0.07 | 0.01 |
| Cash EPS (Rs.) | 0.06 | 0.06 | -0.13 | -0.06 | 0.01 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.02 | 0.97 | 0.30 | 1.06 | 1.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.02 | 0.97 | 0.30 | 1.06 | 1.13 |
| Revenue From Operations / Share (Rs.) | 0.91 | 2.07 | 2.12 | 3.68 | 0.88 |
| PBDIT / Share (Rs.) | 0.10 | 0.05 | -0.14 | -0.03 | 0.01 |
| PBIT / Share (Rs.) | 0.08 | 0.04 | -0.14 | -0.04 | 0.01 |
| PBT / Share (Rs.) | 0.08 | 0.04 | -0.14 | -0.04 | 0.01 |
| Net Profit / Share (Rs.) | 0.04 | 0.05 | -0.14 | -0.06 | 0.01 |
| PBDIT Margin (%) | 11.14 | 2.62 | -6.69 | -1.02 | 2.06 |
| PBIT Margin (%) | 9.58 | 2.00 | -6.94 | -1.10 | 1.73 |
| PBT Margin (%) | 9.48 | 1.98 | -6.95 | -1.10 | 1.67 |
| Net Profit Margin (%) | 5.08 | 2.67 | -6.77 | -1.81 | 1.15 |
| Return on Networth / Equity (%) | 4.55 | 5.67 | -47.59 | -6.28 | 0.90 |
| Return on Capital Employeed (%) | 8.58 | 4.25 | -16.02 | -3.81 | 1.35 |
| Return On Assets (%) | 3.89 | 3.23 | -11.91 | -4.31 | 0.62 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.89 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.63 | 1.42 | 1.54 | 2.30 | 0.58 |
| Current Ratio (X) | 6.92 | 2.14 | 3.83 | 3.15 | 3.11 |
| Quick Ratio (X) | 6.92 | 2.14 | 3.83 | 3.15 | 3.11 |
| Interest Coverage Ratio (X) | 111.40 | 128.60 | -1171.97 | -181.21 | 37.21 |
| Interest Coverage Ratio (Post Tax) (X) | 51.80 | 131.77 | -1183.78 | -320.75 | 21.89 |
| Enterprise Value (Cr.) | 6.97 | 5.39 | 2.70 | 1.60 | 0.81 |
| EV / Net Operating Revenue (X) | 13.94 | 4.77 | 2.33 | 0.79 | 1.66 |
| EV / EBITDA (X) | 125.12 | 181.40 | -34.73 | -77.64 | 80.74 |
| MarketCap / Net Operating Revenue (X) | 13.99 | 4.78 | 2.22 | 0.80 | 2.73 |
| Price / BV (X) | 12.54 | 10.14 | 15.68 | 2.78 | 2.14 |
| Price / Net Operating Revenue (X) | 13.99 | 4.78 | 2.23 | 0.80 | 2.73 |
| EarningsYield | 0.00 | 0.01 | -0.03 | -0.02 | 0.00 |
After reviewing the key financial ratios for Checkpoint Trends Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.02. It has increased from 0.97 (Mar 24) to 1.02, marking an increase of 0.05.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.02. It has increased from 0.97 (Mar 24) to 1.02, marking an increase of 0.05.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.91. It has decreased from 2.07 (Mar 24) to 0.91, marking a decrease of 1.16.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 2. It has increased from 0.05 (Mar 24) to 0.10, marking an increase of 0.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 0.05 (Mar 24) to 0.04, marking a decrease of 0.01.
- For PBDIT Margin (%), as of Mar 25, the value is 11.14. This value is within the healthy range. It has increased from 2.62 (Mar 24) to 11.14, marking an increase of 8.52.
- For PBIT Margin (%), as of Mar 25, the value is 9.58. This value is below the healthy minimum of 10. It has increased from 2.00 (Mar 24) to 9.58, marking an increase of 7.58.
- For PBT Margin (%), as of Mar 25, the value is 9.48. This value is below the healthy minimum of 10. It has increased from 1.98 (Mar 24) to 9.48, marking an increase of 7.50.
- For Net Profit Margin (%), as of Mar 25, the value is 5.08. This value is within the healthy range. It has increased from 2.67 (Mar 24) to 5.08, marking an increase of 2.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.55. This value is below the healthy minimum of 15. It has decreased from 5.67 (Mar 24) to 4.55, marking a decrease of 1.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 10. It has increased from 4.25 (Mar 24) to 8.58, marking an increase of 4.33.
- For Return On Assets (%), as of Mar 25, the value is 3.89. This value is below the healthy minimum of 5. It has increased from 3.23 (Mar 24) to 3.89, marking an increase of 0.66.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 1.42 (Mar 24) to 0.63, marking a decrease of 0.79.
- For Current Ratio (X), as of Mar 25, the value is 6.92. This value exceeds the healthy maximum of 3. It has increased from 2.14 (Mar 24) to 6.92, marking an increase of 4.78.
- For Quick Ratio (X), as of Mar 25, the value is 6.92. This value exceeds the healthy maximum of 2. It has increased from 2.14 (Mar 24) to 6.92, marking an increase of 4.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 111.40. This value is within the healthy range. It has decreased from 128.60 (Mar 24) to 111.40, marking a decrease of 17.20.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 51.80. This value is within the healthy range. It has decreased from 131.77 (Mar 24) to 51.80, marking a decrease of 79.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.97. It has increased from 5.39 (Mar 24) to 6.97, marking an increase of 1.58.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.94. This value exceeds the healthy maximum of 3. It has increased from 4.77 (Mar 24) to 13.94, marking an increase of 9.17.
- For EV / EBITDA (X), as of Mar 25, the value is 125.12. This value exceeds the healthy maximum of 15. It has decreased from 181.40 (Mar 24) to 125.12, marking a decrease of 56.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.99. This value exceeds the healthy maximum of 3. It has increased from 4.78 (Mar 24) to 13.99, marking an increase of 9.21.
- For Price / BV (X), as of Mar 25, the value is 12.54. This value exceeds the healthy maximum of 3. It has increased from 10.14 (Mar 24) to 12.54, marking an increase of 2.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.99. This value exceeds the healthy maximum of 3. It has increased from 4.78 (Mar 24) to 13.99, marking an increase of 9.21.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Checkpoint Trends Ltd:
- Net Profit Margin: 5.08%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.58% (Industry Average ROCE: 16.24%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.55% (Industry Average ROE: 14.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 51.8
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 458 (Industry average Stock P/E: 55.95)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.08%